|
April 1994
(pdf format)
|
Complete Your Training and Certification Download Forms Download the Application and the CMA Test below. Complete both forms and return by mail or email. Mail the Application and Test to: Walter Ginter MARS Project 260 East 161 Street Track Level Bronx, NY 10451 Or email the Application and Test to Walter Ginter: Application and Test…
[Federal Register: January 17, 2001 (Volume 66, Number 11)] [Rules and Regulations] [Page 4075-4102] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr17ja01-9] [[Page 4075]] ———————————————————————– Part II Department of Health and Human Services ———————————————————————– Substance Abuse and Mental Health Services Administration ———————————————————————– 21 CFR Part…
Methadone treatment is entering a new era giving methadone patients opportunities that they never had before. Our views and issues are being taken seriously by many and it is important that advocacy organizations continue their important role as the patient’s voice. It is because of the hard work of many of the NAMA chapters that…
Our Mission Today over a million people in this country are suffering from an addiction to opiates. The fortunate ones are those who have sought treatment… those who take a single dose of medication each day to be free of opiate addiction. It was 50 years ago that a group of three doctors at Rockefeller…
FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…